Skip to content

The Efficacy of Scaling and Root Planing on Endothelin-1 Level

The Efficacy of Scaling and Root Planing on Endothelin-1 Gingival Crevicular Fluid Levels Among Periodontitis Patients: a Randomized Clinical Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06784869
Acronym
clinical
Enrollment
24
Registered
2025-01-20
Start date
2025-02-01
Completion date
2025-09-30
Last updated
2025-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Keywords

periodontitis, endotheiln-1, scaling and root surface debritment

Brief summary

Periodontitis is a chronic inflammatory disease resulting from bacterial invasion. Endothelin (ET-1) is a potent vasoconstrictor critical in the pathophysiology of periodontal diseases. Aim The present study aimed to measure the ET-1 concentrations in gingival crevicular fluid (GCF) at baseline, one and three months subsequently to non-surgical periodontal therapy. Material and methods Designed as a clinical trial, 24 periodontitis individuals will be voluntarily consented to participate. Following non-surgical periodontal treatment, GCF samples will be collected to determine the amount of endothelin-1 at baseline, one, and three months. Clinical periodontal parameters will be recorded.

Detailed description

Periodontitis is a chronic inflammatory disease resulting from bacterial invasion. Endothelin (ET-1) is a potent vasoconstrictor critical in the pathophysiology of periodontal diseases. Aim The present study aimed to measure the ET-1 concentrations in gingival crevicular fluid (GCF) at baseline, one and three months subsequently to non-surgical periodontal therapy. Material and methods Designed as a clinical trial, 24 periodontitis individuals will be voluntarily consented to participate. Following non-surgical periodontal treatment, GCF samples will be collected to determine the amount of endothelin-1 at baseline, one, and three months. Clinical periodontal parameters will be recorded.

Interventions

DEVICEScaling and root surface debritment

Patients with 4-6 mm pocket depth were participated in this study; clinical periodontal parameters (BOP, PLI, PPD, CAL) were recorded at the baseline visit. To ensure sampling accuracy, From the site two papers with GCF were sampled. Following sample collecting for GCF, Every patient received comprehensive mouth supragingival scaling with an ultrasonic scaler (WoodpEEKer® UDS-K) along with dental hygiene recommendations. One week later, the sites were irrigated with normal saline after being scaled and root planed (ScRp) with Gracey curette. Following completion of subgingival instrumentation, each patient returned to the clinic following 1 and 3 months for periodontal parameter recording and GCF collection. Throughout these sessions, every patient received reinstruction to engage in self-oral hygiene practices.

Sponsors

University of Baghdad
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* systemically healthy * Generalized unstable periodontitis with a moderately deep pocket (4,5 or 6 mm)

Exclusion criteria

* subjects who wore dental prosthesis * teeth with grade II mobility, * alcoholic and smoker, had treated caries * underwent periodontal therapy within the last four months

Design outcomes

Primary

MeasureTime frameDescription
PPD3 months recall visitschanges in PPD after non-surgical periodontal treatment.
CAL3 months recall visitschanges in CAL after non-surgical periodontal treatment.

Secondary

MeasureTime frameDescription
ET-13 months recall visitschange in GCF level of Endothelin-1 in 1- and 3- month following the periodontal treatment

Contacts

Primary ContactSarah alrihaymee
sarra.anwar1205a@codental.uobaghdad.edu.iq07828802375

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026